Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]
Nexus Pharmaceuticals Announces Appointment of New Board Members
Nexus Pharmaceuticals, a privately-owned U.S.-based healthcare company, has announced the appointment of Edgar Lee and […]
Niklas Prager Appointed New CEO of SmartCella
SmartCella Holding AB has today announced that Niklas Prager has been appointed as the new […]
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]
RQM+ Acquires Libra Medical
RQM+, the world’s leading MedTech service provider, has announced the acquisition of Libra Medical, a […]
UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment […]
Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]
BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424
BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]
Voyager Therapeutics Announces Appointment of George Scangos, Ph.D., to Board of Directors
Voyager Therapeutics, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, […]
DiogenX Raises €27.5M Series A Financing to Advance its First-In-Class Treatment for Type 1 Diabetes
DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more